Equities

Nanalysis Scientific Corp

Nanalysis Scientific Corp

Actions
  • Price (CAD)0.365
  • Today's Change-0.005 / -1.35%
  • Shares traded35.89k
  • 1 Year change-15.12%
  • Beta0.7098
Data delayed at least 15 minutes, as of Nov 22 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in CAD

The one analyst offering a 12 month price target expects Nanalysis Scientific Corp share price to rise to 1.20 in the next year from the last price of 0.37.
High224.3%1.20
Med224.3%1.20
Low224.3%1.20

Earnings history & estimates in CAD

On Nov 21, 2024, Nanalysis Scientific Corp reported 3rd quarter 2024 losses of -0.02 per share. This result was in line with the expectation of the one analyst following the company and exceeded last year's 3rd quarter results by 66.67%.
Average growth rate+4.17%
Nanalysis Scientific Corp reported annual 2023 losses of -0.16 per share on Apr 29, 2024.
Average growth rate-146.67%
More ▼

Revenue history & estimates in CAD

Nanalysis Scientific Corp. had 3rd quarter 2024 revenues of 10.57m. This bettered the 9.00m estimate of the one analyst covering the company. This was 126.14% above the prior year's 3rd quarter results.
Average growth rate+12.02%
Nanalysis Scientific Corp. had revenues for the full year 2023 of 28.21m. This was 13.63% above the prior year's results.
Average growth rate+34.17%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.